Tag: pharmaceuticals
-

Infographic – Majorities Favor U.S. Vaccine Mandates
As the more contagious delta variant becomes the dominant SARS-CoV-2 strain, a clear majority of American adults now favors employers mandating Covid-19 vaccines.
-

Pharma, Biotech Partner on Off-the-Shelf Cell Therapies
A biotechnology enterprise is teaming with a pharmaceutical company to develop off-the-shelf therapies for malfunctioning mitochondria, energy centers of cells.
-

Fine-Tuning Process Devised for Gene Therapies
Researchers designed a technique to adjust the volume of proteins from gene therapy released into patients, providing more control for complex diseases.
-

Trial Tests Psychedelic Drug Safety, Chemical Activity
A clinical trial is underway that tests an hallucinogenic compound among healthy adults as a potential treatment for mental health disorders.
-

FDA Clears Stem Cell Trial for Multiple Sclerosis
The Food and Drug Administration has authorized a clinical trial of stem cells extracted and cultured from patients to treat their cases of multiple sclerosis.
-

Infographic – Drug Overdose Epidemic Accelerating
While the public’s attention for the past 18 months has been focused on Covid-19, the problem of opioid overdoses and deaths is still with us, and getting worse.
-

ALS Drug Maker Gains $135M in New Funds
A developer of treatments for people with amyotrophic lateral sclerosis, or ALS, is raising $135 million in its third venture financing round.
-

Trial to Test Antibody Drug for Alzheimer’s Prevention
Eli Lilly and Company is partnering with an Alzheimer’s disease research center to test a synthetic antibody for preventing the disorder in at-risk individuals.
-

Immune Cell Cancer Biotech Gains $172M in New Funds
A biotechnology company developing cancer therapies with natural killer cells in the immune system is raising $172 million in its second venture round.
-

$60M Challenge Seeks RNA Bio-Production Network
A new challenge competition aims to build a distributed network of facilities to design, develop, and manufacture RNA-based biologic products.